MULTIPLE MYELOMA RESEARCH FOUNDATION
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1998-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.themmrf.org/
Clinical Trials
3
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
MMRF CureCloud Research Initiative
- Conditions
- Multiple Myeloma
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Multiple Myeloma Research Foundation
- Target Recruit Count
- 1105
- Registration Number
- NCT03657251
- Locations
- 🇺🇸
Multiple Myeloma Research Foundation, Norwalk, Connecticut, United States
🇺🇸Washington University Medical Campus, Saint Louis, Missouri, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
MMRF Molecular Profiling Protocol
- Conditions
- Plasma MalignancyMultiple Myeloma
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Multiple Myeloma Research Foundation
- Target Recruit Count
- 1000
- Registration Number
- NCT02884102
- Locations
- 🇺🇸
Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸UCSF Medical Center, San Francisco, California, United States
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
- Conditions
- Multiple Myeloma
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Multiple Myeloma Research Foundation
- Target Recruit Count
- 1154
- Registration Number
- NCT01454297
- Locations
- 🇺🇸
Mayo Clinic Campus in Scottsdale, AZ, Scottsdale, Arizona, United States
🇺🇸UC San Diego Moores Cancer Center, San Diego, California, United States
🇺🇸Sharp Health Care, San Diego, California, United States
News
MMRF's Horizon Trial Program Enrolls First Patient to Optimize Myeloma Treatment
The Multiple Myeloma Research Foundation (MMRF) has initiated its Horizon Clinical Trials Program, enrolling the first patient in a study of relapsed and refractory myeloma.